BIO vs CBK · rev $2.58B vs P/E 11, $426.5M cap
BIO (BIO) versus Commercial Bancgroup, Inc. Common Stock (CBK) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Commercial Bancgroup, Inc. Common Stock (CBK) is a banks - regional company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
CBK does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. CBK currently screens at market cap $426.5M and trailing P/E 11.2.
Not investment advice. Open the BIO and CBK stock pages for the full models.
Not investment advice.